Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Zivanovic

Showing results (121-130 of 204) with videos related to

Pageof 21
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2020
Randomized Phase II Trial of Nivolumab Versus Nivolumab and Ipilimumab for Recurrent or Persistent Ovarian Cancer: An NRG Oncology StudyDmitriy Zamarin, Robert A Burger, Michael W Sill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2009
Stage-specific outcomes of patients with uterine leiomyosarcoma: a comparison of the international Federation of gynecology and obstetrics and american joint committee on cancer staging systemsOliver Zivanovic, Mario M Leitao, Alexia Iasonos, et al.
Cancers|October 16, 2025
Implementation of Robotic-Assisted Surgery for the Treatment of Patients with Endometrial CarcinomaWalid Shaalan, Kathrin Haßdenteufel, Fabiola Hoppe, et al.
Gynecologic Oncology Reports|August 15, 2022
Small cell neuroendocrine carcinoma of the cervix: Analysis of prognostic factors and patterns of metastasisSushmita Gordhandas, Brooke A Schlappe, Qin Zhou, et al.
Gynecologic Oncology|October 24, 2025
Survival outcomes in patients receiving neoadjuvant chemotherapy for advanced ovarian cancer: Does the indication for neoadjuvant chemotherapy matter?Sarah Andres, Andrew Tannous, Ryan M Kahn, et al.
Gynecologic Oncology|July 9, 2010
The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomasDennis S Chi, Oliver Zivanovic, Kimberly L Levinson, et al.
Gynecologic Oncology|June 26, 2020
Patient reported outcomes measures in gynecologic oncology: A primer for clinical use, part IRachel C Sisodia, Summer B Dewdney, Amanda N Fader, et al.
Gynecologic Oncology|June 26, 2020
Patient reported outcomes measures in gynecologic oncology: A primer for clinical use, Part IIRachel C Sisodia, Summer B Dewdney, Amanda N Fader, et al.
Gynecologic Oncology|June 4, 2015
Predictive value of the Age-Adjusted Charlson Comorbidity Index on perioperative complications and survival in patients undergoing primary debulking surgery for advanced epithelial ovarian cancerRudy S Suidan, Mario M Leitao, Oliver Zivanovic, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 13, 2023
Safety and feasibility of therapeutic anticoagulation for newly diagnosed venous thromboembolism in women who undergo neoadjuvant chemotherapy for advanced ovarian cancerThomas Boerner, Clarissa Lam, Derman Basaran, et al.
Pageof 21

Showing results (121-130 of 204) with videos related to

Sort By:
Pageof 21
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2020
Randomized Phase II Trial of Nivolumab Versus Nivolumab and Ipilimumab for Recurrent or Persistent Ovarian Cancer: An NRG Oncology StudyDmitriy Zamarin, Robert A Burger, Michael W Sill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2009
Stage-specific outcomes of patients with uterine leiomyosarcoma: a comparison of the international Federation of gynecology and obstetrics and american joint committee on cancer staging systemsOliver Zivanovic, Mario M Leitao, Alexia Iasonos, et al.
Cancers|October 16, 2025
Implementation of Robotic-Assisted Surgery for the Treatment of Patients with Endometrial CarcinomaWalid Shaalan, Kathrin Haßdenteufel, Fabiola Hoppe, et al.
Gynecologic Oncology Reports|August 15, 2022
Small cell neuroendocrine carcinoma of the cervix: Analysis of prognostic factors and patterns of metastasisSushmita Gordhandas, Brooke A Schlappe, Qin Zhou, et al.
Gynecologic Oncology|October 24, 2025
Survival outcomes in patients receiving neoadjuvant chemotherapy for advanced ovarian cancer: Does the indication for neoadjuvant chemotherapy matter?Sarah Andres, Andrew Tannous, Ryan M Kahn, et al.
Gynecologic Oncology|July 9, 2010
The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomasDennis S Chi, Oliver Zivanovic, Kimberly L Levinson, et al.
Gynecologic Oncology|June 26, 2020
Patient reported outcomes measures in gynecologic oncology: A primer for clinical use, part IRachel C Sisodia, Summer B Dewdney, Amanda N Fader, et al.
Gynecologic Oncology|June 26, 2020
Patient reported outcomes measures in gynecologic oncology: A primer for clinical use, Part IIRachel C Sisodia, Summer B Dewdney, Amanda N Fader, et al.
Gynecologic Oncology|June 4, 2015
Predictive value of the Age-Adjusted Charlson Comorbidity Index on perioperative complications and survival in patients undergoing primary debulking surgery for advanced epithelial ovarian cancerRudy S Suidan, Mario M Leitao, Oliver Zivanovic, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 13, 2023
Safety and feasibility of therapeutic anticoagulation for newly diagnosed venous thromboembolism in women who undergo neoadjuvant chemotherapy for advanced ovarian cancerThomas Boerner, Clarissa Lam, Derman Basaran, et al.
Pageof 21